CLEVELAND, Aug. 01, 2017 -- Bravo, a nationwide wellness provider, is pleased to announce that it has renewed its partnership with Hooper Holmes, Inc. (OTCQX:HPHW) as preferred biometric screening and flu vaccination partner. Since the company launched 9 years ago, Bravo has relied upon Hooper Holmes as a preferred partner for biometric screenings, having delivered over 25,000 events and 700,000 individual screenings together.
|
|||
“Bravo and Hooper have a tremendous working relationship that has evolved with technology and the changing marketplace,” said Jim Pshock, Bravo Wellness Founder and CEO. “We are excited by Hooper’s growth and their expanding health provider network, which has now reached more than 20,000. Great partnerships require commitment to service excellence and that is what Hooper Holmes continues to provide as one of our key partners.”
Hooper Holmes, Inc., a leading provider of health, wellness and biometric screening services, provides on-site biometric screenings and seasonal flu vaccinations for Bravo’s extensive client base. The core offering features a comprehensive venipuncture screening along with measured biometrics.
“We applaud Jim and the Bravo team for providing best-in-class health and well-being programs for their members,” said Henry Dubois, CEO of Hooper Holmes. “As we have ramped up our service model, expanded our health provider network through our recent merger, and renewed our commitment to the Bravo team, Hooper is well-positioned to assist Bravo in leveraging screenings as a meaningful face-to-face interaction that builds confidence in their wellness program and provides a launching pad for interest in continued program engagement post-screening.”
On-site screenings and flu vaccinations feature Hooper’s nationwide health professional network and technology platforms including its proprietary, ScreeningPro™ tablet technology with online/offline paperless sign-in capabilities.
About Bravo Wellness
Founded in 2008, Bravo’s mission is to inspire people to achieve their personal best. By focusing on individual improvement, Bravo helps employers and health plans leverage wellness to strengthen employee benefits and drive down the long-term claims trend. Their data-driven approach has established proven models for controlling rising healthcare costs, inspiring personal improvement and strengthening existing benefits into a competitive advantage. For more information, visit www.bravowell.com.
About Hooper Holmes
Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, employers and brokers, government organizations and academic institutions nationwide. For more information, visit www.hooperholmes.com.
Contacts Bravo Corporate Marketing 877.662.7286 Hooper Holmes Henry E. Dubois, CEO 913.764.1045


Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Italy Fines Apple €98.6 Million Over App Store Dominance
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 



